Scilex Holding announced that the U.S. Bankruptcy Court for the Southern District of Texas has extended the expiration of the restrictions on transfer of the shares of common stock of Scilex that were previously distributed by Sorrento Therapeutics, Scilex’s former controlling stockholder, to Sorrento’s stockholders as a dividend on January 19, 2023. Such lock-up period was previously set to expire on the earlier of September 30, 2024 or the date on which Sorrento and its Official Committee of Unsecured Creditors agreed in writing or on the record in Sorrento’s chapter 11 cases certain claims that may be asserted in potential litigation to avoid Sorrento’s distribution of Dividend Stock and to recover such Dividend Stock, should not be pursued, or on such date that the Court deems just and proper. On September 25, 2024, the Court approved a motion to extend the lock-up period on the Dividend Stock to January 31, 2025.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SCLX:
- Scilex Settles Debt, Expands Distribution of Non-Opioid Treatments
- Scilex announces the continuing support from Endeavor Distribution
- Scilex recieved the Drug Distributor Accredidation from NABP
- Scilex announces acceptance of presentation at ACRC conference
- Scilex’s Semnur Pharmaceuticals Set for Strategic Merger with Denali
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue